
Covid-19 Vaccine Suppliers & Bulk Manufacturers
Available Forms: Vial for reconstitution (injectable, intramuscular)
Available Strengths: 30 µg per dose
Reference Brands: Comirnaty
Category: Nanoemulsion/Nanoparticles
COVID-19 Vaccine is available in Vial for reconstitution (injectable, intramuscular) and strengths such as 30 µg per dose. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, COVID-19 Vaccine is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
COVID-19 Vaccine can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description:
Comirnaty (Pfizer-BioNTech COVID-19 vaccine) is regulated in the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality compliant with GMP standards. FDA approval involved extensive clinical validation, safety monitoring, and efficacy data, while in the EU, CE marking certifies conformity with MDR standards. Both regions require validation, stability testing, and audits, supported by comprehensive documentation including safety profiles, clinical trial results, and quality management systems. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective COVID-19 vaccines supporting global health efforts and pandemic control.
Frequently Asked Questions
Related Products
Givosiran Infusion
Strength: 2.5 mg/kg IV infusion
Form: Intravenous infusion
Reference Brands: Givlaari
View DetailsPatisiran Infusion
Strength: 0.3 mg/mL
Form: Intravenous (IV) infusion
Reference Brands: Onpattro
View DetailsQuick Response Guaranteed | Verified Suppliers